These "cholinesterase inhibitors" include tacrine (Cognex), donepezil (Aricept), rivastigmine (Exelon) and galantamine (Razadyne, formerly called Reminyl).
It's unclear if the results would apply to other cholinesterase inhibitors such as galantamine (Razadyne) or rivastigmine (Exelon), the editorial noted.